TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33452957

Group type: EXPERIMENTAL
Intervention: ONCE Dialyze (370 kcal/day for 30 days)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NEPRO (370 kcal/day for 30 days)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: ONCE Dialyze
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NEPRO
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control
Number of subjects: 80
Study: 35096113

Group type: EXPERIMENTAL
Intervention: Ginger (500 mg twice a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 34893880

Group type: EXPERIMENTAL
Intervention: Abstinence
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ad lib use
Number of subjects: 15
Study: 33694167

Group type: EXPERIMENTAL
Intervention: Explicit teaching of the stem conservation rule in derived words
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Implicit teaching of the stem conservation rule in derived words
Number of subjects: 90

Group type: COMPARATOR
Intervention: Unseen control group (no explicit or implicit teaching)
Number of subjects: 90
Study: 32893346

Group type: EXPERIMENTAL
Intervention: Organizational internal locus of control
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Conflictual communication
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 367

Group type: EXPERIMENTAL
Intervention: Organizational climate
Number of subjects: 367
Study: 34369681

Group type: EXPERIMENTAL
Intervention: TEAS (transcutaneous electrical acupoint stimulation)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (placebo TEAS)
Number of subjects: 49
Study: 32864799

Group type: EXPERIMENTAL
Intervention: Cisplatin with radiation
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cetuximab with radiation
Number of subjects: 2
Study: 33350726

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 100
Study: 33632884

Group type: EXPERIMENTAL
Intervention: Thrombectomy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 33
Study: 33278255

Group type: EXPERIMENTAL
Intervention: Cervical headgear
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cervical headgear and utility arch
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 60
Study: 32819025

Group type: EXPERIMENTAL
Intervention: Sim-Insole with auditory feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard bathroom scale (BS) method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sim-Insole without feedback
Number of subjects: 20
Study: 32799397

Group type: EXPERIMENTAL
Intervention: DrugFactsBox with SMART program
Number of subjects: 286

Group type: COMPARATOR
Intervention: DrugFactsBox without SMART program
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Other consumer medication information (CMI) with SMART program
Number of subjects: 286

Group type: COMPARATOR
Intervention: Other CMI without SMART program
Number of subjects: 286
Study: 32495663

Group type: EXPERIMENTAL
Intervention: Multiple-dose GnRH-a
Number of subjects: 80

Group type: COMPARATOR
Intervention: Single-dose GnRH-a
Number of subjects: 80
Study: 34633758

Group type: EXPERIMENTAL
Intervention: Kami Guibi-tang (KGT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32746864

Group type: COMPARATOR
Intervention: 0.75% bupivacaine with 20 μg of fentanyl (1 ml)
Number of subjects: 300

Group type: COMPARATOR
Intervention: 0.75% bupivacaine with 5 μg of DEX (1 ml)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 0.75% bupivacaine with saline (1 ml)
Number of subjects: 300
Study: 36398589

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brain Health education (Control)
Number of subjects: 0
Study: 32838555

Group type: EXPERIMENTAL
Intervention: Trust-based continuous quality improvement intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imputation and per protocol approaches
Number of subjects: 0
Study: 36454357

Group type: EXPERIMENTAL
Intervention: XP‐endo Finisher
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control (no XP‐endo Finisher)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Both groups (XP‐endo Finisher and Control)
Number of subjects: 92
Study: 33579766

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop system
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sensor-augmented pump therapy
Number of subjects: 72
Study: 32357269

Group type: EXPERIMENTAL
Intervention: High-frequency theta burst stimulation
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-frequency theta burst stimulation
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional subthalamic DBS
Number of subjects: 17
Study: 36125791

Group type: EXPERIMENTAL
Intervention: Glare (continuous, off‐axis)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No glare
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Glare and No glare (both conditions)
Number of subjects: 40
Study: 34067240

Group type: EXPERIMENTAL
Intervention: Supplementation with Harpagophytum procumbens, Zingiber officinale and Bixa orellana (2 g/day in 6 doses for 4 weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 28
Study: 32371830

Group type: EXPERIMENTAL
Intervention: PEEP set according to Poeso measurement
Number of subjects: 44

Group type: COMPARATOR
Intervention: PEEP constantly set at 5 cmH2O (control group)
Number of subjects: 44
Study: 34037888

Group type: EXPERIMENTAL
Intervention: Parental Friendship Coaching (PFC)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Coping with ADHD through Relationships and Education (CARE)
Number of subjects: 172
Study: 34021963

Group type: EXPERIMENTAL
Intervention: Higher Demodex density (greater than 5 mites/cm2)
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Demodex density
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Concomitant dermatological disease
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Frequent cosmetic use
Number of subjects: 349
Study: 33491091

Group type: EXPERIMENTAL
Intervention: Low Glycemic Load (GL) diet
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low Glycemic Load (GL) meal
Number of subjects: 30

Group type: COMPARATOR
Intervention: High Glycemic Load (GL) meal
Number of subjects: 30
Study: 35790450

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry (MTC) juice
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry (MTC) capsules
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Montmorency tart cherry (MTC) supplementation
Number of subjects: 44
Study: 36038585

Group type: COMPARATOR
Intervention: Zinc acetate 50 mg × 3 daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Zinc gluconate 50 mg × 3
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Zinc acetate 150 mg × 1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Zinc gluconate 150 mg × 1
Number of subjects: 40
Study: 33037644

Group type: EXPERIMENTAL
Intervention: Education sessions for interns, residents, and clinical pharmacists about appropriate analgesic prescribing.
Number of subjects: 973
Study: 35087650

Group type: EXPERIMENTAL
Intervention: Periodic oropharyngeal aspiration
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine nursing measures (Control)
Number of subjects: 96
Study: 33006602

Group type: EXPERIMENTAL
Intervention: 30 mg of diclofenac etalhyaluronate (DF-HA) intra-articularly at weeks 0, 4, and 8
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 32208038

Group type: EXPERIMENTAL
Intervention: Iron isomaltoside 1000/ferric derisomaltose (IIM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 0
Study: 36216432

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (triggered by Hb ≤100 g/L)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (triggered by Hb ≤70 g/L)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy
Number of subjects: 742

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy
Number of subjects: 742
Study: 34554027

Group type: EXPERIMENTAL
Intervention: Vacuum‐lock bag (VB group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Thermoplastic mask (TM group)
Number of subjects: 100
Study: 33962104

Group type: EXPERIMENTAL
Intervention: lncRNAs identified from medaka testis
Number of subjects: 5317

Group type: EXPERIMENTAL
Intervention: Cis-regulated target genes predicted from lncRNAs
Number of subjects: 5317

Group type: EXPERIMENTAL
Intervention: Target genes involved in biological pathways
Number of subjects: 5317

Group type: EXPERIMENTAL
Intervention: MSTRG.14827.1 lncRNA
Number of subjects: 5317
Study: 33445924

Group type: EXPERIMENTAL
Intervention: Hem-o-lok clips
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Endoloop
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Stapler
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 120
Study: 33484775

Group type: EXPERIMENTAL
Intervention: Elafibranor 80 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Elafibranor 120 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Elafibranor
Number of subjects: 45
Study: 34961398

Group type: EXPERIMENTAL
Intervention: Making health care decisions
Number of subjects: 2037

Group type: EXPERIMENTAL
Intervention: Predicting health care decisions
Number of subjects: 2037

Group type: EXPERIMENTAL
Intervention: Perceived social norms
Number of subjects: 2037
Study: 34612663

Group type: EXPERIMENTAL
Intervention: Probiotic group (Bifidobacterium lactis Probio‐M8 powder and Symbicort Turbuhaler)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo group (placebo and Symbicort Turbuhaler)
Number of subjects: 55
Study: 32775408

Group type: EXPERIMENTAL
Intervention: Nomogram for Overall Survival (OS)
Number of subjects: 6395

Group type: EXPERIMENTAL
Intervention: Nomogram for Cancer-Specific Survival (CSS)
Number of subjects: 6395

Group type: COMPARATOR
Intervention: Nomogram vs. histological type in Decision Curve Analysis (DCA)
Number of subjects: 6395
Study: 35099597

Group type: EXPERIMENTAL
Intervention: Cementless tibial components
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cemented tibial components
Number of subjects: 53
Study: 33314326

Group type: COMPARATOR
Intervention: RP3128 (25, 50, 100, 200, and 400 mg single doses; 25, 100, and 400 mg once daily for 7 days)
Number of subjects: 56

Group type: COMPARATOR
Intervention: RP3128
Number of subjects: 56
Study: 35918787

Group type: EXPERIMENTAL
Intervention: eHealth intervention for HRQOL
Number of subjects: 331

Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 331
Study: 36266713

Group type: EXPERIMENTAL
Intervention: Endoscopic combined intrarenal surgery (ECIRS) in the prone split-leg position
Number of subjects: 66

Group type: COMPARATOR
Intervention: Endoscopic combined intrarenal surgery (ECIRS) in the Galdakao-modified supine Valdivia (GMSV) position
Number of subjects: 66
Study: 34394889

Group type: EXPERIMENTAL
Intervention: Shexiang Baoxin pill (given on the basis of conventional treatment)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Conventional treatment (control group)
Number of subjects: 206
Study: 33172321

Group type: EXPERIMENTAL
Intervention: Balance training on a force platform with visual feedback technique
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional physiotherapy (hot pack therapy, interferential current, myofascial relaxation, cervical dynamic isometric exercises)
Number of subjects: 30
Study: 34557087

Group type: EXPERIMENTAL
Intervention: Metamizole 1,000 mg three times daily for 7 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily for 7 days
Number of subjects: 15
Study: 32371514

Group type: EXPERIMENTAL
Intervention: Farmers' Market Nutrition Coupon Programme (FMNCP)
Number of subjects: 132

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 132
Study: 35988569

Group type: EXPERIMENTAL
Intervention: Surgical reconstruction
Number of subjects: 316

Group type: COMPARATOR
Intervention: Rehabilitation (physiotherapy)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Comparison of surgical reconstruction to rehabilitation
Number of subjects: 316
Study: 32530733

Group type: EXPERIMENTAL
Intervention: Two-dose EV71 vaccination
Number of subjects: 408664
Study: 32997262

Group type: EXPERIMENTAL
Intervention: Thulium Laser Enucleation of the Prostate (ThuLEP)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Holmium Laser Enucleation of the Prostate (HoLEP)
Number of subjects: 236
Study: 32539432

Group type: EXPERIMENTAL
Intervention: Online training in family-centered relational skills strategy (LAFF)
Number of subjects: 15
Study: 32129511

Group type: EXPERIMENTAL
Intervention: Self-administration of romiplostim (n = 621)
Number of subjects: 754

Group type: COMPARATOR
Intervention: HCP administration of romiplostim (n = 133)
Number of subjects: 754

Group type: EXPERIMENTAL
Intervention: Self-administration of romiplostim
Number of subjects: 754

Group type: COMPARATOR
Intervention: HCP administration of romiplostim
Number of subjects: 754
Study: 36229844

Group type: EXPERIMENTAL
Intervention: Laparoscopic colectomy
Number of subjects: 96
Study: 36090743

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation (24 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard rehabilitation (3 sessions per week for around 60 min)
Number of subjects: 0
Study: 35777773

Group type: EXPERIMENTAL
Intervention: F ENO-based asthma management (adjustment of asthma treatment according to exhaled nitric oxide and symptoms every 6-12 weeks)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: F ENO-based asthma management
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care (no treatment adjustment as part of the trial)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1200
Study: 35339112

Group type: EXPERIMENTAL
Intervention: Physical activity recommendations (PAR group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT group)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: HIIT together with whole-body electromyostimulation (HIIT + EMS group)
Number of subjects: 65

Group type: COMPARATOR
Intervention: No exercise (control group)
Number of subjects: 65
Study: 32444994

Group type: EXPERIMENTAL
Intervention: BAX602 spray
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 34256389

Group type: EXPERIMENTAL
Intervention: Reduced volume for a single set (RV1, n=20)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Reduced volume for two sets (RV2, n=19)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Maintained volume of three sets (MV, n=18)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Pre-conditioning phase (20 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 57
Study: 34693688

Group type: EXPERIMENTAL
Intervention: Cellex (1 ml subcutaneously once daily for 10 days)
Number of subjects: 60
Study: 32663909

Group type: EXPERIMENTAL
Intervention: Decoglurant 5 mg
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Decoglurant 15 mg
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Decoglurant 30 mg
Number of subjects: 357

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 357
Study: 35815985

Group type: EXPERIMENTAL
Intervention: Progressive bridging exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional exercise
Number of subjects: 48
Study: 34840669

Group type: EXPERIMENTAL
Intervention: Melatonin 0.5 mg/kg once a day, in the morning (MEL group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (placebo group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Melatonin (MEL group)
Number of subjects: 36
Study: 33509400

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthy lifestyles (specific foods and modest sunlight exposure)
Number of subjects: 0
Study: 35057520

Group type: EXPERIMENTAL
Intervention: RF‐EMFs emitted by two different mobile phone types
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham radiation
Number of subjects: 15
Study: 33802115

Group type: EXPERIMENTAL
Intervention: Nutri‐Score (N‐S)
Number of subjects: 4504

Group type: EXPERIMENTAL
Intervention: Multiple Traffic Light (MTL)
Number of subjects: 4504

Group type: EXPERIMENTAL
Intervention: Warning Label (WL)
Number of subjects: 4504

Group type: EXPERIMENTAL
Intervention: Positive Choice tick (PC)
Number of subjects: 4504

Group type: COMPARATOR
Intervention: No label control
Number of subjects: 4504
Study: 35199841

Group type: EXPERIMENTAL
Intervention: Intelligent Volume Assured Pressure Support (iVAPS)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Spontaneous/timed (S/T) mode
Number of subjects: 80
Study: 33882012

Group type: EXPERIMENTAL
Intervention: AI chatbot using bidirectional encoder representations from transformers model
Number of subjects: 118008

Group type: EXPERIMENTAL
Intervention: AI chatbot using LSTM model with embedding vectors
Number of subjects: 118008
Study: 34817419

Group type: EXPERIMENTAL
Intervention: Self-care and communication intervention for parents
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low-dose control
Number of subjects: 110
Study: 32512690

Group type: EXPERIMENTAL
Intervention: Stand-biased desks
Number of subjects: 97

Group type: COMPARATOR
Intervention: Traditional sitting desks
Number of subjects: 97
Study: 35286569

Group type: EXPERIMENTAL
Intervention: Zolpidem 5 mg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 11
Study: 33617777

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (5 × 10^10 viral particles)
Number of subjects: 24178

Group type: COMPARATOR
Intervention: Control vaccine or saline placebo
Number of subjects: 24178
Study: 32144955

Group type: EXPERIMENTAL
Intervention: Zanubrutinib 480 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zanubrutinib 160 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 32185994

Group type: EXPERIMENTAL
Intervention: Low frequency group (1 time/week for five weeks)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High frequency group (2 times/week for two weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low frequency group
Number of subjects: 60

Group type: COMPARATOR
Intervention: High frequency group
Number of subjects: 60
Study: 34214161

Group type: EXPERIMENTAL
Intervention: T2D group (232 participants)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: DKD group (87 patients)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: DMSs in TXNIP and CPT1A
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis
Number of subjects: 232

Group type: COMPARATOR
Intervention: Nondiabetic controls (197 participants)
Number of subjects: 232
Study: 34362445

Group type: EXPERIMENTAL
Intervention: 12-month external implementation intervention including developmental evaluation, on-site visit, and monthly facilitation calls.
Number of subjects: 8
Study: 35342923

Group type: EXPERIMENTAL
Intervention: LAIV4
Number of subjects: 151

Group type: COMPARATOR
Intervention: IIV4
Number of subjects: 151
Study: 33789322

Group type: EXPERIMENTAL
Intervention: Lumbar orthosis (back brace) with back school instruction
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (education and exercise instruction alone)
Number of subjects: 61
Study: 32487980

Group type: EXPERIMENTAL
Intervention: Orthopedic insoles with metatarsal retro-capital bar (MRCB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Orthopedic insoles without correction (Control)
Number of subjects: 20
Study: 36434739

Group type: EXPERIMENTAL
Intervention: CT-P39
Number of subjects: 146

Group type: COMPARATOR
Intervention: EU-omalizumab
Number of subjects: 146

Group type: COMPARATOR
Intervention: US-omalizumab
Number of subjects: 146
Study: 33338583

Group type: EXPERIMENTAL
Intervention: Ashwagandha 300 mg, twice daily, orally for 8 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo, twice daily, orally for 8 weeks
Number of subjects: 80
Study: 36247201

Group type: EXPERIMENTAL
Intervention: Ordinary dietary pattern
Number of subjects: 1693

Group type: COMPARATOR
Intervention: High-fat dietary pattern
Number of subjects: 1693
Study: 32638144

Group type: EXPERIMENTAL
Intervention: HFHF enhanced with STS
Number of subjects: 248

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 248
Study: 36187084

Group type: EXPERIMENTAL
Intervention: EXER (loading programme specific to Achilles tendon combined with physical therapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EXER and ESWT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: EXER, ESWT and PBMT
Number of subjects: 60

Group type: COMPARATOR
Intervention: EXER
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patient preference and satisfaction with treatment
Number of subjects: 60
Study: 35225548

Group type: EXPERIMENTAL
Intervention: Reinforced plication with recession procedure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard resection with recession procedure
Number of subjects: 80
Study: 34171280

Group type: EXPERIMENTAL
Intervention: Pharmacokinetic-guided treatment group
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 66
Study: 35282825

Group type: EXPERIMENTAL
Intervention: Air polishing with a conical shaped tip
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sonic scaling
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 44
Study: 35383741

Group type: EXPERIMENTAL
Intervention: Nebulized 3% hypertonic saline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (0.9%) with salbutamol
Number of subjects: 100
Study: 32925650

Group type: EXPERIMENTAL
Intervention: Secondary IOL surgery
Number of subjects: 114

Group type: COMPARATOR
Intervention: Primary IOL placement
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Secondary IOL surgery after 4½ years
Number of subjects: 114